Cannabis M&A

Trulieve’s NYSE uplisting may become one of the most important cannabis capital markets milestones in recent years.

Retail portfolios, strategic acquisitions, real estate, and manufacturing are attracting increasing attention as cannabis enters a new phase.

Many cannabis disputes begin long before litigation. Learn practical strategies for managing expectations, communication, and conflict.

What happens when dispensaries finally accept credit cards? Schedule III could reshape cannabis retail forever.

California cannabis operators are entering a critical DEA registration window under Schedule III medical cannabis rules.

California operators may now reposition medical cannabis licenses as Schedule III and FDA alignment reshape the market.

The hemp THC ban is reshaping cannabis. Here is who wins, who loses, and what comes next.

The intoxicating hemp ban could disrupt gummies, beverages, and vapes while strengthening regulated cannabis markets.

Cannabis Schedule 3 and 280E reform could drive M&A, boost valuations, and reshape cannabis real estate across the market.

Los Angeles retail rents are slowing, creating new risks and opportunities across cannabis real estate, leases, and M&A.

Cannabis M&A consolidation in California is accelerating as major players align production and distribution through strategic deals.

420 cannabis sales surge 2026 could be the most mainstream yet as consumer demand, vapes, and M&A trends converge.

New FDA and CMS developments may reshape cannabis M&A, business valuations, and real estate as federal regulation expands.

FDA regulation of cannabis and hemp businesses may transform product standards, valuations, and real estate as federal oversight expands.

Smart money is moving into cannabis property for sale in California as the market shifts from distress to strategic consolidation and growth.

After years of distress, the California cannabis market may be approaching a turning point as consolidation accelerates and investors re-enter.

Tilray’s $44 million BrewDog acquisition signals a major shift as a Canadian cannabis company expands into craft beer, positioning itself for future THC beverage markets.

A stalled multi-million dollar expansion reveals the real cannabis business growth challenges behind rapid scale in cultivation and real estate.

Cannabis sales are hitting records in both the U.S. and Canada. With Schedule III reform advancing, growth is fueling investment and M&A.

Nature’s Miracle plans a $150 million greenhouse in California City. Here is how its scale compares to Glass House and what it means for the California flower market.